More about

Vaccination

News
November 05, 2024
2 min read
Save

RSV vaccine shows ‘quite impressive’ ability to prevent hospitalization in older adults

RSV vaccine shows ‘quite impressive’ ability to prevent hospitalization in older adults

Respiratory syncytial virus vaccines proved highly effective at preventing hospitalization and ED visits in older adults, even in those with immunocompromising conditions, results from an observational analysis showed.

News
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

Q&A: App ‘much better’ than physicians at diagnosing ear infections

More than half of children with acute otitis media and 32% of children with upper respiratory infections tested positive for multiple pathogens in their nasal passages, according to a study presented at IDWeek.

News
October 31, 2024
2 min read
Save

COVID-19 vaccination rates plummet among nursing home personnel

COVID-19 vaccination rates plummet among nursing home personnel

There was a “marked decrease” in COVID-19 vaccine uptake among nursing home personnel last season, according to researchers, who attributed the decline to cost and the end of the CMS’s COVID-19 vaccine requirement in mid-2023.

News
October 29, 2024
3 min read
Save

Study raises questions about need for mpox booster doses

Study raises questions about need for mpox booster doses

LOS ANGELES — Neutralizing antibodies against mpox generated by the Jynneos vaccine were short lived — lasting less than a year — if patients had never received a smallpox vaccine as children, researchers said.

News
October 24, 2024
5 min read
Save

Boy’s punctured cheek swells with pain, erythema

Boy’s punctured cheek swells with pain, erythema

A healthy, 10-year-old boy seeks care for a sore left cheek.

News
October 23, 2024
2 min read
Save

CDC recommends 2nd COVID shot for some, lowering age for pneumococcal vaccination

CDC recommends 2nd COVID shot for some, lowering age for pneumococcal vaccination

A CDC advisory committee on Wednesday recommended that adults aged 65 years or older and anyone who is at least moderately immunocompromised receive a second dose of COVID-19 vaccine this season.

News
October 23, 2024
4 min read
Save

Merck’s RSV shot for infants shows promise, could be available in 2025

Merck’s RSV shot for infants shows promise, could be available in 2025

Another monoclonal antibody for preventing respiratory syncytial virus disease in infants could enter the market as early as next year, based on the results of two studies presented at IDWeek, Merck said.

News
October 22, 2024
2 min watch
Save

VIDEO: Paxlovid effective for people with prior immunity, study shows

VIDEO: Paxlovid effective for people with prior immunity, study shows

LOS ANGELES — Paxlovid reduced the risk for severe COVID-19 hospitalization or death among people with existing immunity from a previous infection or vaccination, according to pooled trial data presented at IDWeek.

News
October 22, 2024
2 min read
Save

Top in ID: Cockroaches potential infection vector; NDM-positive drug-resistant infection

Top in ID: Cockroaches potential infection vector; NDM-positive drug-resistant infection

A 20-month outbreak of multidrug-resistant Enterobacter cloacae in an ICU was associated with the presence of cockroaches, according to a study that linked outbreak strains to strains found in the insects.

News
October 22, 2024
5 min read
Save

Lack of diverse training, nonspecific symptoms leave physicians challenged to identify measles

Lack of diverse training, nonspecific symptoms leave physicians challenged to identify measles

A combination of several factors makes it tough for providers to identify measles cases as the disease makes a comeback, according to experts.

View more